Functional Impact at 12 Months Post-op of Posterior Cruciate Ligament Conservation During Robotic-assisted Surgery (MAKO) for Total Knee Replacement.
LCPTG
Evaluation of the Functional Impact at 12 Months Post-op of Posterior Cruciate Ligament Conservation During Robotic-assisted Surgery (MAKO) for Total Knee Replacement. A Randomized, Single-blind, Multicenter, Controlled Superiority Study.
1 other identifier
interventional
300
1 country
3
Brief Summary
Studies have been made on the best way to do knee surgery and whether to conserve the posterior cruciate ligament or not during total knee prosthesis insertion is still under debate. However, most of these studies were made before the introduction of robotic knee surgery. It seems timely to do a study comparing these two surgical techniques: preservation versus removal of the posterior cruciate ligament in knee arthroplasty
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2025
CompletedFirst Submitted
Initial submission to the registry
March 18, 2026
CompletedFirst Posted
Study publicly available on registry
March 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
March 27, 2026
March 1, 2026
1.5 years
March 18, 2026
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Functional impact at of posterior cruciate ligament preservation in the LCP+group
Evaluated according to the FJS-12 (Forgotten Joint Score) self-questionnaire. The FJS-12 is a self-administered questionnaire consisting of 12 items. The patient is asked to rate their awareness of their artificial joint for the 12 activities. Each item is then given a score of between 0-4 on a five-point Likert scale in which : 0 - Never,1 - Almost Never, 2 - Seldom, 3 - Sometimes,4 - Mostly. The answers are then summed and divided by the number of completed items. The mean value is then multiplied by 25 to obtain the total score of 0-100. The higher scores indicating better outcomes (less awareness of the joint).
12 months post-surgery
Functional impact at of posterior cruciate ligament resection in the LCP-group
Evaluated according to the FJS-12 (Forgotten Joint Score) self-questionnaire. The FJS-12 is a self-administered questionnaire consisting of 12 items. The patient is asked to rate their awareness of their artificial joint for the 12 activities. Each item is then given a score of between 0-4 on a five-point Likert scale in which : 0 - Never,1 - Almost Never, 2 - Seldom, 3 - Sometimes,4 - Mostly. The answers are then summed and divided by the number of completed items. The mean value is then multiplied by 25 to obtain the total score of 0-100. The higher scores indicating better outcomes (less awareness of the joint).
12 months post-surgery
Secondary Outcomes (17)
Functional impact at of posterior cruciate ligament preservation in the LCP+group
4.5 months post-surgery
Functional impact at of posterior cruciate ligament ablation in the LCP-group
4.5 months post-surgery
Algo-functional OKS (Oxford Knee Score) in the LCP+group
4.5 months post-surgery
Algo-functional OKS (Oxford Knee Score) in the LCP+group
12 months post-surgery
Algo-functional OKS (Oxford Knee Score) in the LCP-group
4.5 months post-surgery
- +12 more secondary outcomes
Study Arms (2)
LCP+ group
EXPERIMENTALRobot-assisted total knee arthroplasty with conservation of the posterior cruciate ligament
LCP- group
ACTIVE COMPARATORRobot-assisted total knee arthroplasty with ablation of the posterior cruciate ligament
Interventions
Eligibility Criteria
You may qualify if:
- Patient scheduled for first-intention robotic-assisted total knee replacement (MAKO).
- Unilateral replacement, regardless of laterality.
- Patient able to answer questionnaires.
- Patient willing to undergo usual 12-month follow-up.
- Patient has given free and informed consent and has signed the consent form.
- Patient affiliated with or benefiting from a health insurance scheme.
You may not qualify if:
- Patient with intraoperative technical impossibility of retaining PCL (flessum \> 20°, flexion stiffening \< 100°).
- Previous posterior cruciate ligament surgery.
- Post-traumatic gonarthrosis.
- Valgus \> 185°.
- Patient with septic complication.
- Patient participating in another interventional trial.
- Patient under court protection, guardianship or curatorship.
- Patient unable to give consent.
- Patients for whom it is impossible to provide informed information.
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire de Nīmeslead
- Clinique Tivoli Ducoscollaborator
- Hôpital de la Croix-Roussecollaborator
Study Sites (3)
Clinique Tivoli-Ducos
Bordeaux, 33000, France
Hôpital Croix Rousse
Lyon, 69317, France
Nîmes University Hospital
Nîmes, 30029, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pascal KOUYOUMDJIAN, Pr.
Nîmes University Hospital
- PRINCIPAL INVESTIGATOR
Julien BARDOU-JACQUET, Dr.
Clinique Tivoli-Ducos, Bordeaux
- PRINCIPAL INVESTIGATOR
Sébastien LUSTIG, Pr.
Hôpital Croix Rousse, Lyon
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The patient will not know whether he/she is in the LCP+ group (preservation of the posterior cruciate ligament) or the LCP- group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2026
First Posted
March 24, 2026
Study Start
October 10, 2025
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
September 1, 2028
Last Updated
March 27, 2026
Record last verified: 2026-03